| Literature DB >> 20596534 |
Yacine Kharraz1, Pierre-Adrien Salmand, Anne Camus, Jacques Auriol, Cyril Gueydan, Véronique Kruys, Dominique Morello.
Abstract
BACKGROUND: TIA-1-related (TIAR) protein is a shuttling RNA-binding protein involved in several steps of RNA metabolism. While in the nucleus TIAR participates to alternative splicing events, in the cytoplasm TIAR acts as a translational repressor on specific transcripts such as those containing AU-Rich Elements (AREs). Due to its ability to assemble abortive pre-initiation complexes coalescing into cytoplasmic granules called stress granules, TIAR is also involved in the general translational arrest observed in cells exposed to environmental stress. However, the in vivo role of this protein has not been studied so far mainly due to severe embryonic lethality upon tiar invalidation. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20596534 PMCID: PMC2893167 DOI: 10.1371/journal.pone.0011352
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Generation and characterization of mice carrying a transgene allowing tissue-specific expression of TIAR.
(A) Schematic representation of the GFP-TIAR transgene and recombination by Cre recombinase. (B) Analysis of transgene expression in mouse tissues by western blot using anti-GFP antibodies. Twenty µg of proteins extracted from the indicated tissues were used for western blot analysis. GFP expression was observed using anti-GFP antibodies and the amount of loaded proteins in the different samples was tested using anti-TIAR antibody (Tg or WT: transgenic or WT tissues respectively).
Figure 2Transmission of the transgene.
GFP-TIAR transgene transmission (%) upon mating heterozygous GFP-TIAR males with PGK-Cre or Sycp1-Cre transgenic females. n: number of pups genotyped three weeks after birth using TIAR primers.
Figure 3Correlation between transgene copy number and transgene expression.
(A) Left: scheme of partial (TIAR-GFPΔp) or complete (TIAR-GFPΔt) deletion of GFP cassettes upon Cre recombinase activity in vivo. Right: PCR amplification from tail DNA of GFP-TIAR, TIAR-GFPΔp, TIAR-GFPΔt males with primer sets amplifying GFP or endogenous and transgenic TIAR sequences. (B) In vivo expression of TIAR-Flag upon excision of GFP cassettes by PGK-Cre. Semi-quantitative RT-PCR was performed with total RNA from testis of WT, TIAR-GFPΔp and TIAR-GFPΔt mice. Three primer sets were used to detect endogenous and transgenic TIAR (upper lanes), transgenic TIAR (middle lanes) and S16 control mRNAs (lower lanes), respectively. The number of PCR cycles at which a fraction of the PCR reaction was analyzed, is indicated. (C) Western blot analysis of transgenic TIAR expression upon in vivo excision of GFP cassettes by PGK-Cre. Twenty µg of protein extracts of testis from the indicated males were loaded on the gel. The indicated antibodies were used to detect transgenic GFP, transgenic TIAR (FLAG) or endogenous TIAR a and b isoforms (TIAR). Asterisk indicates a non-specific band detected by the anti-Flag antibody. Incubation with anti-tubulin antibody indicates that similar amounts of proteins were loaded on the gel.
Figure 4Impaired development of TIAR overexpressing embryos at post-implantation stages.
(A) Embryonic lethality within descendants from crossing GFP-TIAR males with WT or PGK-Cre expressing females. The values correspond to the % of empty decidua or abnormal embryos found in pregnant PGK-Cre or WT females mated with GFP-TIAR transgenic males between 9.5 and 17.5 dpc. n: number of counted decidua. (B-D) Representative pictures of post-implantation development of GFP-TIAR x PGK-Cre embryos collected between 5.5 dpc and 7.5 dpc from pregnant PGK-Cre females mated with heterozygous GFP-TIAR males. Magnification 20× for all embryos but 10× for the normal E7.5 embryo shown in D on the left. (B) Left: pre-streak stage embryo. Note that the distal VE has not started to shift proximally (arrowhead). The anterior movement of distal VE cells converts Proximal-Distal polarity to Anterior-Posterior polarity in the pregastrula embryo; Right: pre-streak stage embryo with abnormal thickening of the VE (arrowhead) and reduced ExE (asterisk). (C) Left: Gastrulation has started in this early-streak stage embryo with the formation of the primitive streak posteriorly; Right: pre-streak stage embryo with distal VE (arrowhead). (D) Left: Gastrulation is completed and the three germ layers are established in this early-neural-plate stage embryo. The primitive streak has extended to reach the distal tip of the embryo where a node has formed (black arrowhead). The amnion is closed and an allantois bud is visible (white arrowhead). Middle: Abnormally small embryo with a reduced ExE (asterisk), thin-looking epiblast layer (white arrowhead) and expanded pro-amniotic cavity. Note distally the abnormal accumulation of the VE (black arrowhead); Right: Abnormally small embryo with a reduced ExE (asterisk) and no visible primitive streak or node. (E) Post-implantation lethality. Embryos from pregnant PGK-Cre females mated with homozygous GFP-TIAR males were collected between 5.5 and 7.5 dpc and the number of empty decidua, delayed/abnormal or normal embryos was counted. n: number of analyzed decidua.
Figure 5In utero vs in vitro development of TIAR overexpressing embryos.
(A) Pre-implantation embryos from pregnant WT females mated with homozygous GFP-TIAR males were collected at various pre-implantation stages and observed for GFP expression. GFP expression starts at morula (mo) stage and persists at the early blastocyst stage (bl) where the blastocoele cavity starts to be clearly visible when observed upon bright field. (B) E3.5 embryos were collected from uterus of WT or PGK-Cre females mated with homozygous GFP-TIAR (TIAR) males, stained for TIAR and observed under confocal microscope using TOPRO to visualize the nucleus of each blastomere. The first column shows representative pictures of blastocysts while the second column shows blastomere magnification. IIary antibodies correspond to embryos for which the first step of labelling (anti-TIAR antibody) has been omitted to assess background fluoresence. (C) E3.5 embryos were collected from uterus of WT or PGK-Cre females mated with WT or homozygous GFP-TIAR (TIAR) males and the % of “healthy” blastocysts with no obvious fragmentation was counted. (D) Embryos from WT or PGK-Cre females mated with WT or homozygous GFP-TIA (TIAR) males were collected at E0.5 or E2.5, cultured in M16 medium until WT embryos hatched (for 2-4 days) and the % of “healthy” blastocysts with no obvious fragmentation was counted. n: number of counted embryos.
Figure 6Increased sensitivity of PGK-Cre x GFP-TIAR blastocysts to in vitro culture correlated with accumulation of phospho-eIF2α in cytoplasmic granules.
(A,B) Representative pictures of embryos from WT or PGK-Cre x GFP-TIAR (TIAR) crosses grown in vitro in M16 (A) or G2 (B) medium until they reach hatched blastocyst stage. A. in M16 fragmentation and unevensized blastomeres are observed in TIAR compared to healthy looking hatched WT blastocysts. In G2 medium the TIAR embryos are not distinguishable from WT ones (B). (C) WT or PGK-Cre x GFP-TIAR (TIAR) embryos cultured from 8-cell stage to blastocyst stage in G2 or M16 medium were fixed and stained with anti-phospho-eIF2α antibody and TOPRO to label nuclei and observed by confocal microscopy. WT embryos express GFP while GFP has been deleted in Cre-expressing embryos (TIAR), as shown in merge pictures. While artefactual phospho-eIF2α staining due to TOPRO labelling is observed in the nuclei of all types of embryos, phospho-eIF2α accumulates only in the cytoplasm of TIAR embryos grown in M16 medium. Shown are representative images obtained from two independent experiments where 5–20 embryos of each categories were analyzed. The scale bars represent 10 µm.
Figure 7Potential associations between proteins encoded by TIAR-associated mRNAs and expressed during pre-implantation stages.
Interconnection revealed using String database (http://string.embl.de/) between 29 proteins encoded by mRNAs specifically bound by TIAR and which are expressed in pre-implantation development.
List of functionally or physically interconnected proteins encoded by mRNAs specifically immunoprecipitated by TIAR in RAW264.7 cells and expressed in pre-implantation development.
| Groups | Accession number | Symbol | Gene name | ARE cluster |
| Trp53/TNF-α | NM_011640 | Trp53 | transformation related protein 53 | No ARE |
| NM_013693 | Tnf | tumor necrosis factor | Cluster 3 | |
| NM_007707 | Socs3 | suppressor of cytokine signaling 3 | Cluster 5 | |
| NM_010431 | Hif1a | hypoxia inducible factor 1, alpha subunit | Cluster 3 | |
| NM_011400 | Slc2a1 | solute carrier family 2 (facilitated glucose transporter), member 1 | Cluster 5 | |
| NM_013719 | Eif2ak4 | eukaryotic translation initiation factor 2 alpha kinase 4 | No ARE | |
| NM_025848 | Sdhd | succinate dehydrogenase complex, subunit D | No ARE | |
| NM_007671 | Cdkn2c | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | No ARE | |
| NM_008654 | Ppp1r15a | protein phosphatase 1, regulatory (inhibitor) subunit 15a | Cluster 1 | |
| NM_133819 | Ppp1r15b | protein phosphatase 1, regulatory (inhibitor) subunit 15b | No Are | |
| NM_007464 | Birc3 | baculoviral IAP repeat-containing 3 | No ARE | |
| NM_013760 | Dnajb9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | No ARE | |
| Pax6 | NM_009715 | Atf2 | activating transcription factor 2 | Cluster 5 |
| NM_013498 | Crem | cAMP responsive element modulator | No ARE | |
| NM_013627 | Pax6 | paired box gene 6 | Cluster 5 | |
| NM_009361 | Tfdp1 | transcription factor Dp 1 | No ARE | |
| NM_009578 | Ikzf1 | zinc finger protein, subfamily 1A, 1 (Ikaros) | No ARE | |
| Prka | NM_021788 | Sap30 | sin3 associated polypeptide | No ARE |
| NM_009030 | Rbbp4 | retinoblastoma binding protein 4 | Cluster 5 | |
| NM_026785 | Ube2c | ubiquitin-conjugating enzyme E2C | No ARE | |
| NM_011121 | Plk1 | polo-like kinase 1 (Drosophila) | No ARE | |
| NM_011100 | Prkacb | protein kinase, cAMP dependent, catalytic, beta | No ARE | |
| NM_007656 | Kai1 | kangai 1 (suppression of tumorigenicity 6, prostate) | No ARE | |
| NM_025280 | Kin | antigenic determinant of rec-A protein | No ARE | |
| NM_011158 | Prkar2b | protein kinase, cAMP dependent regulatory, type II beta | Cluster 5 | |
| NM_134010 | Nup107 | nucleoporin 107 | No ARE | |
| NM_009282 | Stag1 | stromal antigen 1 | Cluster 5 | |
| NM_008854 | Prkaca | protein kinase, cAMP dependent, catalytic, alpha | No ARE | |
| NM_007896 | Mapre1 | microtubule-associated protein, RP/EB family, member 1 | No ARE |
The list of TIAR RNA ligands was generated from RIP-Chip data performed in triplicate by immunoprecipitating stably expressed TIAR-Flag or RRM2-lacking TIAR-Flag mutant with anti-Flag-coupled sepharose beads. RNAs binding full-length but not truncated TIAR protein were included in the list, several of which were confirmed by RIP-qRT-PCR.